American Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
VPM
VCM
B
American Capital Management's NEO Position: Q1 2026 in Review
American Capital Management reduced its NeoGenomics (NEO) stake by 3.2% in Q1 2026, selling an estimated $773K and leaving 2,250,878 shares worth $16.7M. The position accounts for 0.9% of the portfolio, ranked #34.
American Capital Management first reported a position in NEO in Q4 2018 and has held it in 19 quarters since. The position peaked at $27.3M in Q4 2025. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.
- American Capital Management held 2,250,878 shares of NeoGenomics worth $16.7M as of Q1 2026.
- American Capital Management sold 73,488 NeoGenomics shares in Q1 2026, an estimated $773K.
- NeoGenomics made up 0.9% of American Capital Management's portfolio in Q1 2026, its #34 holding.
- American Capital Management first reported a position in NeoGenomics in Q4 2018 and has held it in 19 quarters since.
- American Capital Management's NeoGenomics position peaked at $27.3M in Q4 2025.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.
Based on American Capital Management's 13F filing for Q1 2026, filed 15 May 2026.